Patents
Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
03/2007
03/08/2007US20070054905 Use of indole-derived compounds for the preparation of a medicament that can be used to treat diseases related to the splicing process
03/08/2007US20070054881 Anxiolytic agents with reduced sedative and ataxic effects
03/07/2007EP1758911A1 1-heterocyclyl-1,5-dihydro-pyrido[3,2-b]indol-2-ones
03/07/2007EP1758903A1 Pyrrolopyramidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists
03/07/2007CN1926107A Weakly basic hindered amines having carbonate skeletons, synthetic resin compositions, and coating compositions
03/06/2007US7186730 Bicyclic nitrogen-containing heterocyclic derivatives for use as antibacterials
03/06/2007CA2167694C Catharanthus roseus binary alkaloid antimitotic derivatives
03/01/2007WO2007023582A1 Standard sample for test and/or calibration of circular dichroism dispersion meter and uv-visible spectrophotometer
03/01/2007US20070049607 Triazolo [4,5-d] pyrimidine derivatives and their use as purinergic receptor antagonists
03/01/2007US20070049580 Anxiolytic agents with reduced sedative and ataxic effects
02/2007
02/28/2007EP1757608A1 New benzazepine derivatives, medicaments containing the same and their use in the preparation of medicaments
02/28/2007EP1756120A1 Purine derivative
02/28/2007EP1756104A1 Tetrahydronaphthyridine derivatives useful as histamine h3 receptor ligands
02/28/2007EP1756103A2 Pyrrolopyridine derivatives and their use as hiv-integrase inhibitors
02/28/2007EP1509522B1 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands
02/28/2007EP1461335B1 2-heteroarylcarboxylic acid amides
02/28/2007EP1425286B1 Substituted 7-aza-[2.2.1]bicycloheptanes for the treatment of diseases
02/28/2007EP1309592B9 Substituted pyrazoles
02/28/2007CN1922182A Pyrrolotriazine compounds as kinase inhibitors
02/28/2007CN1922180A Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
02/28/2007CN1922171A Pyrimidine derivative
02/27/2007US7183413 Aminoquinoline compounds
02/27/2007US7183282 N'-methyl-2-[(p-fluorophenyl)-4-oxo-butyl]piperazino[1,2-fg]gamma-carboline; N'-methyl-2-[p-fluorophenoxypropyl]piperazino[1,2-fg]gamma-carboline; serotonin modulators; sleep disorders; central nervous system disorders
02/22/2007WO2006091897A3 Derivatives of 8-substituted xanthines
02/22/2007WO2006091896A3 Pyridyl substituted xanthines
02/22/2007WO2006062981A3 Antagonists to the vanilloid receptor subtype 1 (vr1) and uses thereof
02/22/2007US20070043074 2-(4-methylphenyl),3-(thien-2-yl-carbonyl),6-(methyl)imidazo(1,2-a)pyridine; GABA receptor inhibitors; anxiiolytic agents; sleep disorders (insomnia); psychological disorders; anticonvulsants; aggressiveness; antispasmodic agents; antidepressants/ bipolar disorders;cognition activators; analgesics
02/22/2007US20070043069 3-Amino-3,4-dihydro-1,5-naphthyridin-2(1H)-one and its dihydrochloride; intermediates for producing naphthyridinylaminocarbonyl-substituted pyrrolothiopyrans and imidazolothiopyrans
02/22/2007US20070043063 Such as 3-(2-Methanesulfonyl-pyrimidin-4-yl)-5-pyridin-3-yl-1-(toluene-4-sulfonyl)-1H-pyrrolo[2,3-b]pyridine; heart disease, diabetes, Alzheimer's disease, immunodeficiency disorders, inflammatory diseases, hypertension, allergic diseases, autoimmune diseases, destructive bone disorders
02/22/2007US20070043039 Tumor suppression agents with reduced side effects; anticancer; antibacterial and antiviral
02/22/2007US20070042439 Porphyrin compound containing biotinyl group and use thereof
02/21/2007EP1754707A2 Multicyclic compounds and their use as inhibitors of PARP, VEGFR2 and MLK3 enzymes
02/21/2007EP1753858A2 Novel saccharothrix strain and antibiotics derived therefrom, i.e. mutactimycins and aldgamycins
02/21/2007EP1753766A1 Tetraazabenzo(e)azulene derivatives and analogs thereof
02/21/2007CN1918172A 利福霉素类似物及其用途 Rifamycin analogs and their use
02/20/2007US7179927 Extraction method
02/20/2007US7179801 Cephem compounds
02/20/2007US7179794 Antibiotics; bactericides
02/20/2007US7179493 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
02/15/2007WO2007017750A1 Benzoate salt of 4-(5-methyl-oxazolo[4,5-b]pyridin-2-yl)-1,4-diaza-bicyclo[3.2.2]nonane
02/15/2007WO2006067614B1 Heteroaromatic derivatives useful as anticancer agents
02/14/2007EP1751166A1 Mono-, oligo- and polythieno[3,2-b]thiophenes
02/14/2007EP1751157A1 Inhibitors of the hiv integrase enzyme
02/14/2007EP1751156A1 6,7,8,9-substituted 1-phenyl-1,5-dihydro-pyrido(3,2-b)indol-2-ones useful as anti-infective pharmaceutical agents
02/14/2007EP1562944B1 Pyrazoloquinolines with immunomodulating activity
02/14/2007CN1911930A Chemokine receptor anagonists, methods and use therefor
02/14/2007CN1300110C Hydroxamate derives useful as deacetylase inhibitors
02/13/2007US7176313 A oxoquinolines or a 4-oxo-1,8-naphthyridines or 7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazine derivative for the treatment of tuberculosis, exhibits no cross resistance
02/13/2007US7176210 Cannabinoid receptor ligands and uses thereof
02/13/2007US7176195 Treatment of nocturnal enuresis, nocturia, polyuria resulting from central diabetes insipidus, urinary incontinence or bleeding disorders such a hemophilia
02/08/2007US20070032640 Cytokine receptor
02/08/2007US20070032528 inhibitors of vascular endothelial growth factor receptor tyrosine kinase; antiproliferative agents; antitumor; 4-Hydroxy-3-(5-methylbenzimidazol-2-yl)hydropyridino[3,4-b]pyridin-2-one; nitrogen containing cyclic compounds
02/07/2007EP1230241B1 Adenosine receptor antagonists and methods of making and using the same
02/07/2007CN1909906A 2,6-disubstituted piperidines as modulators of chemokine receptor activity
02/07/2007CN1298720C Sinomenine derivative with C cycle connected to penetabasic heterocycle and synthesizing method
02/06/2007US7173039 Compounds that modulate or inhibit enzymes for occular diseases
02/01/2007WO2007013691A1 Spiro-cyclic compound
02/01/2007US20070027200 Bis-benzimidazoles and related compounds as potassium channel modulators
02/01/2007CA2617042A1 Spiro-cyclic compound
01/2007
01/31/2007EP1747779A1 Tetrahydro-b-carbolin-sulfonamide derivatives as 5-HT6 ligands
01/31/2007CN1297555C Antagonists of MCP-q function and method of use thereof
01/30/2007US7169922 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings
01/30/2007US7169794 Oxidation of a chemical intermediate
01/30/2007US7169786 Strong anti-depressant activity without being sedative; serotonin (5-HT) reuptake inhibitor activity in combination with additional alpha 2-adrenoceptor antagonist activity
01/30/2007CA2238316C N-([1,2,4]triazoloazinyl)benzenesulfonamide and pyridinesulfonamide compounds and their use as herbicides
01/25/2007WO2005118777A8 Novel saccharothrix strain and antibiotics derived therefrom, i.e. mutactimycins and aldgamycins
01/25/2007US20070021428 2-Substituted phenyl-1,3-dihydropyrazolo(4,3-c)cinnolines, e.g., N-[3-(tert-butyl-methyl-amino)-butyl]-4-(6-fluoro-3-oxo-1,3-dihydro-pyrazolo[4,3-c]cinnolin-2-yl)-benzamide, are CD80 antagonists capable of inhibiting the interactions between CD80 and CD28, used for treating autoimmune diseases
01/25/2007US20070020562 Optical information-recording medium, novel oxonol compound and method of recording information
01/24/2007CN1902761A 有机薄膜晶体管 The organic thin film transistor
01/23/2007US7166723 5-hydroxy- or 1-glyceryl-substituted quinolines, isoquinolines or cinnolines as chemical intermediates
01/23/2007US7166596 Heterocyclic aromatic compounds useful as growth hormone secretagogues
01/23/2007CA2334820C Process for the synthesis of carbapenem intermediates, and compounds produced
01/18/2007US20070015732 Adenosine receptor antagonists and methods of making and using the same
01/17/2007EP1742953A1 Process for isolation of ergot alkaloids from ergot
01/17/2007EP1336612B1 Novel carbapenem derivatives
01/17/2007CN1898201A Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents
01/17/2007CN1896078A Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors
01/17/2007CN1895673A The use of substituted tetracyclic imidazole derivatives as anti-histaminics
01/16/2007US7164017 Exhibit electrophysiological activity
01/16/2007US7163703 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
01/16/2007CA2254755C Hexahydro-pyrido(4,3-b)indole derivatives as antipsychotic drugs
01/11/2007US20070010672 Inks, colorants, pigmented plastics for coatings, non-impact-printing material, color filters, cosmetics, polymeric ink particles, toners, fluorescent tracers; high in the efficiency of electrical energy utilisation and high in luminance
01/11/2007US20070010522 Triazolo[1,5-c]pyrimidines and pyrazolo[1,5-c]pyrimidines useful as a2a adenosine receptor antagonists
01/10/2007CN1894259A Rifamycin analogs and uses thereof
01/10/2007CN1894250A Substituted 8-heteroaryl xanthines
01/10/2007CN1894238A Diamine derivatives
01/10/2007CN1894195A Ether compounds and compositions for cholesterol management and related uses
01/10/2007CN1893953A Tricyclic 1-((3-indol-3-yl)carbonyl)piperazine derivatives as cannabinoid cb1 receptor agonists
01/10/2007CN1294130C Substituted pyrazoles
01/09/2007US7160873 Texaphyrin coordination compounds and uses thereof
01/04/2007WO2006067614A3 Heteroaromatic derivatives useful as anticancer agents
01/04/2007US20070004710 6-({2-[4-(6-Methoxy-[1,5]naphthyridin-4-yl)phenyl]ethylamino}methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one;bacterial infections; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli
01/04/2007US20070003957 Real-time linear detection probes: sensitive 5'-minor groove binder-containing probes for PCR analysis
01/03/2007EP1737864A1 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments
01/03/2007EP1737860A1 Selected cgrp-antagonists, their preparation processes and their use as medicaments
01/03/2007EP1737854A1 NOVEL 2-(1-AZA-BICYCLO[2.2.2]OCT-3-yl)-2,3-DIHYDROISOINDOL-l-ONE/5,6-DIHYDRO-FURO[2,3-c]PYRROL-4ONE DERIVATIVES LIGANDS FOR ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR
01/03/2007EP1668012A4 Method for preparing cucurbiturils
01/03/2007CN1890247A Porphyrin/phthalocyanine dimer and tetramer directly bonded at pi system and processes for producing these
01/03/2007CN1293080C Process for the preparation of clopidogrel
01/02/2007US7157489 HIV protease inhibitors
1 ... 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 ... 111